Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians

Cited by (1,005)

Items 901–1,000 of 1,005

1. DETECTION OF A NEW N-OXIDIZED METABOLITE OF FLUTAMIDE, N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]HYDROXYLAMINE, IN HUMAN LIVER MICROSOMES AND URINE OF PROSTATE CANCER PATIENTS
   Rika Goda, Daichi Nagai, Yuji Akiyama · 2006 · Drug Metabolism and Disposition
2. Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical.
   Kenneth S. Lown, Mita Ghosh, Paul Brent Watkins · 1998 · PubMed
3. Reactive metabolite activation by CYP2C19-mediated rhein hepatotoxicity
   Li-Na He, Ai‐Hong Yang, Tianyi Cui et al. · 2014 · Xenobiotica
4. Genetic Factors for Ischemic and Hemorrhagic Stroke in Japanese Individuals
   Yoshiji Yamada, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Sachiro Watanabe, Sahoko Ichihara, Yukitoshi Aoyagi et al. · 2008 · Stroke
5. Comparison of Basal Gene Expression and Induction of CYP3As in HepG2 and Human Fetal Liver Cells
   Masataka Maruyama, Tamihide Matsunaga, Eri Harada · 2007 · Biological and Pharmaceutical Bulletin
6. Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation.
   Stephanie R. Faucette, Roy L. Hawke, Stacy Shifflett Shord · 2001 · PubMed
7. Differential Genotype Dependent Inhibition of CYP2C9 in Humans
   Vikas Kumar, Richard C. Brundage, William S. Oetting · 2008 · Drug Metabolism and Disposition
8. Coumarins and P450s, Studies Reported to-Date
   Maryam K. Foroozesh, Jayalakshmi Sridhar, Navneet Goyal, Jiawang Liu · 2019 · Molecules
9. Chemomodulatory action of Foeniculum vulgare (Fennel) on skin and forestomach papillomagenesis, enzymes associated with xenobiotic metabolism and antioxidant status in murine model system
   B. Singh, R.K. Kale · 2008 · Food and Chemical Toxicology
10. Effect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus Monkeys
    Akihito Ogasawara, Toshiyuki Kume, Emiko Kazama · 2006 · Drug Metabolism and Disposition
11. Acetaldehyde as Well as Ethanol Is Metabolized by Human CYP2E1
    Satoru Kunitoh, Susumu Imaoka, Toyoko Hiroi, Yoshiyasu Yabusaki, Takeyuki Monna, Yoshihiko Funae · 1997 · Journal of Pharmacology and Experimental Therapeutics
12. Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor.
    Kelem Kassahun, I S McIntosh, Magang Shou · 2001 · PubMed
13. The effects of steady‐state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers
    Gary J. Muirhead, Stephen Faulkner, Jane A. Harness · 2002 · British Journal of Clinical Pharmacology
14. Growth Hormone Releasing Peptide-2 (GHRP-2), Like Ghrelin, Increases Food Intake in Healthy Men
    Blandine Laferrère, Cynthia Abraham, Colleen D. Russell, Cyril Y. Bowers · 2005 · The Journal of Clinical Endocrinology & Metabolism
15. Differences in the Urinary Excretion of 6‐β‐Hydroxycortisol/Cortisol between Asian and Caucasian Women
    Yi‐Xin Lin, Gail D. Anderson, Eric D. Kantor, Linda Moretti Ojemann, Alan J. Wilensky · 1999 · The Journal of Clinical Pharmacology
16. The CYP3A4*3 Allele: Is It Really Rare?
    Ron H. N. van Schaik, Saskia N. de Wildt, Rebecca Brosens · 2001 · Clinical Chemistry
17. Polymorphic Cytochromes P450 and Drugs Used in Psychiatry
    Ronald T. Coutts, Liana Urichuk · 1999 · Cellular and Molecular Neurobiology
18. Differential Time-Dependent Inactivation of P450 3A4 and P450 3A5 by Raloxifene: A Key Role for C239 in Quenching Reactive Intermediates
    Josh T. Pearson, Jan L. Wahlstrom, Leslie J. Dickmann, Santosh Kumar, James R. Halpert, Larry C. Wienkers, R. Foti, Dan A. Rock · 2007 · Chemical Research in Toxicology
19. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking
    Eline M. Rodenburg, Mark Eijgelsheim, Johanna Marianne Geleijnse, Najaf Amin, Cornelia M. van Duijn, Albert Hofman D, André Gerardus Uitterlinden, Bruno H. Ch. Stricker, Loes E. Visser · 2012 · American Journal of Clinical Nutrition
20. Trapping of cis-2-Butene-1,4-dial to Measure Furan Metabolism in Human Liver Microsomes by Cytochrome P450 Enzymes
    Leah A. Gates, Ding Lu, Lisa A. Peterson · 2011 · Drug Metabolism and Disposition
21. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin
    Yi-Dong Yan, Dae Hwan Kim, Jun Ho Sung · 2010 · International Journal of Pharmaceutics
22. What is the contribution of human FMO3 in the N -oxygenation of selected therapeutic drugs and drugs of abuse?
    Lea Wagmann, Markus R. Meyer, Hans H. Maurer · 2016 · Toxicology Letters
23. In vitro CYP-mediated drug metabolism in the zebrafish (embryo) using human reference compounds
    Moayad A. Saad, An Matheeussen, Sebastiaan Bijttebier et al. · 2017 · Toxicology in Vitro
24. PharmGKB summary
    Ellen M. McDonagh, Catherine A. Wassenaar, Sean P. David, Rachel Fynvola Tyndale, Russ Biagio Altman, Michelle Whirl‐Carrillo, Teri E. Klein · 2012 · Pharmacogenetics and Genomics
25. Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytes
    Imen Ayed‐Boussema, Jean‐Marc Pascussi, Patrick Maurel · 2010 · Environmental Toxicology and Pharmacology
26. Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan
    Martin J. Wild, D. McKillop, Caroline Butters · 1999 · Xenobiotica
27. Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms
    Anthony B. Renwick, Dominic D. Surry, Roger J. Price · 2000 · Xenobiotica
28. Zolmitriptan Intranasal: A Review of the Pharmacokinetics and Clinical Efficacy
    Peter James Goadsby, Roger Yates · 2006 · Headache The Journal of Head and Face Pain
29. Pharmacogenomics of Sex Difference in Chemotherapeutic Toxicity
    Jeffrey Wang, Ying Sheng Huang · 2007 · Current Drug Discovery Technologies
30. Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity
    D.F.V. Lewis, Maurice Dickins, Brian G. Lake · 1999 · Toxicology
31. Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners
    D. F. V. LEWIS*, Brian G. Lake · 1997 · Xenobiotica
32. Gene–environment interactions in esophageal cancer
    Marco Matejcic, Mohamed Iqbal Parker · 2015 · Critical Reviews in Clinical Laboratory Sciences
33. The Influence of the CYP3A4*22 Polymorphism on Serum Concentration of Quetiapine in Psychiatric Patients
    Karen van der Weide, Jan van der Weide · 2014 · Journal of Clinical Psychopharmacology
34. Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole
    Chiyo K. Imamura, Kenichi Furihata, Shinichiro Okamoto · 2015 · The Journal of Clinical Pharmacology
35. A Functional Polymorphism in the CYP3A4 Gene is Associated with Increased Risk of Coronary Heart Disease in the Chinese Han Population
    Baoxia He, Lei Shi, Jian Qiu, Liang Tao, Rui Li, Liang Yang, Zhao Shu-jin · 2010 · Basic & Clinical Pharmacology & Toxicology
36. CYP3A4*22 and CYP3A Combined Genotypes Both Correlate With Tacrolimus Disposition in Pediatric Heart Transplant Recipients
    Violette M. G. J. Gijsen, Ron HN van Schaik, Laure Elens, Offie Porat Soldin, Steven J. Soldin, Gideon Koren, Saskia N. de Wildt · 2013 · Pharmacogenomics
37. Clinical impact of patient population differences and genomic variation in efavirenz therapy
    Jennifer R. King, Judith A. Aberg · 2008 · AIDS
38. Reliable High-throughput Method for Inhibition Assay of 8 Cytochrome P450 Isoforms Using Cocktail of Probe Substrates and Stable Isotope-labeled Internal Standards
    Kazumasa Kozakai, Yasuhiro Yamada, Motoji Oshikata, Taiji Kawase, Etsuko Suzuki, Yukari Haramaki, Hideki Taniguchi · 2012 · Drug Metabolism and Pharmacokinetics
39. Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
    Minako Sugiyama, Ken‐ichi Fujita, Norie Murayama, Yuko Akiyama, Hiroshi Yamazaki, Yasutsuna Sasaki · 2011 · Drug Metabolism and Disposition
40. Current knowledge of microRNA-mediated regulation of drug metabolism in humans
    Masataka Nakano, Miki Nakajima · 2018 · Expert Opinion on Drug Metabolism & Toxicology
41. Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) to review the toxicology of a number of dyes illegally present in food in the EU
    European Food Safety Authority (EFSA) · 2005 · EFSA Journal
42. CYP3A5 Contributes Significantly to CYP3A-mediated Drug Oxidations in Liver Microsomes from Japanese Subjects
    Satoshi Yamaori, Hiroshi Yamazaki, Shunsuke Iwano, Kazuma Kiyotani, Keiko Matsumura, Goro Honda, Kazuko Nakagawa, Takashi Ishizaki, Tetsuya Kamataki · 2004 · Drug Metabolism and Pharmacokinetics
43. Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P4502C9 in the oxidation of tolbutamide and warfarin by human liver microsomes
    Hiroshi Yamazaki, Kiyoshi Inoue, Tsutomu Shimada · 1998 · Xenobiotica
44. Characterization of (??)-bufuralol hydroxylation activities in liver microsomes of Japanese and Caucasian subjects genotyped for CYP2D6
    Tsutomu Shimada, Fujiko Tsumura, Hiroshi Yamazaki · 2001 · Pharmacogenetics
45. Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals
    Bregt S Kappelhoff, Alwin D. R. Huitema, Zeynep Yalva · 2005 · Clinical Pharmacokinetics
46. Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms
    Anthony B. Renwick, H. Mistry, Simon E. Ball, D. G. WALTERS, J. Kao, Brian G. Lake · 1998 · Xenobiotica
47. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6
    Linda B. von Weymarn, Sharon E. Murphy · 2003 · Xenobiotica
48. Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study
    Chi‐Chen Hong, Bing-Kou Tang, Geoffrey L. Hammond, David Tritchler, Martin J. Yaffe, Norman F. Boyd · 2004 · Breast Cancer Research
49. Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption.
    R. Badhan, J. Penny, A. Galetin, J. Houston · 2009 · Journal of Pharmacy and Science
50. Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
    Jung‐Ryul Kim, Hyo‐Bum Seo, Joo‐Youn Cho · 2008 · British Journal of Clinical Pharmacology
51. Separation and detection methods for covalent drug–protein adducts
    Shu‐Feng Zhou · 2003 · Journal of Chromatography B
52. Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites
    Michael S. Ching, Carolyn L. Blake, Hany Ghabrial, S. Wynne Ellis, Martin S Lennard, Geoffrey T. Tucker, Richard A. Smallwood · 1995 · Biochemical Pharmacology
53. Expression of Cytochrome P450 2A6 in Escherichia coli: Purification, Spectral and Catalytic Characterization, and Preparation of Polyclonal Antibodies
    Pavel Souček · 1999 · Archives of Biochemistry and Biophysics
54. CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam.
    L M Hesse, Karthik Venkatakrishnan, Lisa Lvon Moltke · 2001 · PubMed
55. Scaling Drug Biotransformation Data from cDNA-Expressed Cytochrome P-450 to Human Liver: A Comparison of Relative Activity Factors and Human Liver Abundance in Studies of Mirtazapine Metabolism
    Elke Störmer, Lisa Lvon Moltke, David J. Greenblatt · 2000 · Journal of Pharmacology and Experimental Therapeutics
56. In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data
    Sumit Arora, Isha Taneja, Muralikrishna Challagundla · 2015 · Toxicology Letters
57. Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers
    Tabassome Simon, Laurent Becquemont, Brigitte Hamon-Vilcot, Emmanuel Nouyrigat, Y. Chodjania, Jean‐Marie Poirier, Christian Funck‐Brentano, Patrice Jaillon · 2001 · British Journal of Clinical Pharmacology
58. Untitled work
    2001 · Indian Journal of Pharmacology
59. Impact of CYP3A4*1G polymorphism on metabolism of fentanyl in Chinese patients undergoing lower abdominal surgery
    Ruimei Yuan, Xianwei Zhang, Qian Deng · 2011 · Clinica Chimica Acta
60. Induction of CYP3A by Ethanol in Multiple In Vitro and In Vivo Models
    Dennis E. Feierman, Zoya Melinkov, Amin A. Nanji · 2003 · Alcoholism Clinical and Experimental Research
61. Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety
    Jianling Wang, László Urbán, Dejan Bojanic · 2007 · Expert Opinion on Drug Metabolism & Toxicology
62. Recent advances in pharmacogenetic approaches to anticancer drug development
    Nicola F. Smith, William Douglas Figg, Alex Sparreboom · 2004 · Drug Development Research
63. Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies
    Claire Belloc, Susan Baird, José Cosme · 1996 · Toxicology
64. Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples 1 1Abbreviation: CYP, cytochrome P450.
    Jason R. Baker, Soisungwan Satarug, Paul E.B. Reilly · 2001 · Biochemical Pharmacology
65. Prediction of in Vivo Hepatic Metabolic Clearance of YM796 from in Vitro Data by Use of Human Liver Microsomes and Recombinant P-450 Isozymes
    Takafumi Iwatsubo, Hiroshi I. Suzuki, Noriaki Shimada · 1997 · Journal of Pharmacology and Experimental Therapeutics
66. Inhibition of Human Cytochrome P450 Enzymes 3A4 and 2D6 by β‐Carboline Alkaloids, Harmine Derivatives
    Ting Zhao, Yuqi He, Jun Wang, Ke‐min Ding, Changhong Wang, Zhengtao Wang · 2011 · Phytotherapy Research
67. Identification of cytochrome P450 isoforms involved in 1-hydroxylation of pyrene
    Yong‐Dae Kim, Hidekazu Todoroki, Tsunehiro Oyama · 2003 · Environmental Research
68. Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
    Bertrand Rochat · 2009 · Current Cancer Drug Targets
69. Sesamin: A Naturally Occurring Lignan Inhibits CYP3A4 by Antagonizing the Pregnane X Receptor Activation
    Yun-Ping Lim, Chia-Yun Ma, Cheng‐Ling Liu · 2012 · Evidence-based Complementary and Alternative Medicine
70. Modulation of Cytochrome P450 Metabolism and Transport across Intestinal Epithelial Barrier by Ginger Biophenolics
    Rao Mukkavilli, Sushma R. Gundala, Chunhua Yang, Shashikiran Donthamsetty, Guilherme Henrique Cantuaria, Gajanan Jadhav, Subrahmanyam Vangala, Michelle Dian Reid, Ritu Aneja · 2014 · PLoS ONE
71. Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism
    Nael Al Koudsi, Rachel Fynvola Tyndale · 2010 · Xenobiotica
72. Immunochemical Detection of Cytochrome P450 Enzymes in Liver Microsomes of 27 Cynomolgus Monkeys
    Shotaro Uehara, Norie Murayama, Yasuharu Nakanishi · 2011 · Journal of Pharmacology and Experimental Therapeutics
73. Theophylline: a review of population pharmacokinetic analyses
    Y. J., D. Q. Jiang, J. X. Meng, M. X. Li, Haijin Zhao, Y. Wang, L. Q. Wang · 2016 · Journal of Clinical Pharmacy and Therapeutics
74. In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms
    R. Abbas, Chun P. Chow, Nicholas Browder · 2000 · Human & Experimental Toxicology
75. Drug-Associated Disease: Cytochrome P450 Interactions
    Henry J. Mann · 2006 · Critical Care Clinics
76. What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?
    Vural Özdemir, Neil H. Shear, WERNER KALOW · 2001 · Drug Safety
77. Role of cDNA-Expressed Human Cytochromes P450 in the Metabolism of Diazepam
    Tian Jian Yang, Magang Shou, Kenneth R. Korzekwa · 1998 · Biochemical Pharmacology
78. Intraindividual Variability in Male Hepatic CYP3A4 Activity Assessed by Alfentanil and Midazolam Clearance
    Evan D. Kharasch, Carole Jubert, Tauri Senn, Andrew T. Bowdle, Kenneth E. Thummel · 1999 · The Journal of Clinical Pharmacology
79. Organochlorine insecticides: impacts on human HepG2 cytochrome P4501A, 2B activities and glutathione levels
    P.F. Dehn, S. Allen-Mocherie, J. Karek · 2004 · Toxicology in Vitro
80. Allelic expression imbalance of the human CYP3A4 gene and individual phenotypic status
    Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Shinji Maegawa, Masakiyo Hosokawa, Kaoru Kobayashi, Kan Chiba, Eiji Nanba, Mitsuo Oshimura, Tetsuo Satō et al. · 2004 · Human Molecular Genetics
81. Interaction between midazolam and clarithromycin in the elderly
    Sara K. Quinney, Barbara D. Haehner, Melissa Rhoades · 2007 · British Journal of Clinical Pharmacology
82. Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole*
    Yoseph Caraco, Grant R. Wilkinson, Alastair J. J. Wood · 1996 · Clinical Pharmacology & Therapeutics
83. Andrographolide and 14-Deoxy-11, 12-Didehydroandrographolide inhibit cytochrome P450s in HepG2 hepatoma cells
    Jer Ping Ooi, Masanori Kuroyanagi, Shaida Fariza Sulaiman, Tengku Sifzizul Tengku Muhammad, Ming Tan · 2011 · Life Sciences
84. A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults
    Ibrahim Ince, Saskia N. de Wildt, Chengueng Wang · 2013 · Clinical Pharmacokinetics
85. Human Cytochromes Mediating Sertraline Biotransformation: Seeking Attribution
    David J. Greenblatt, Lisa Lvon Moltke, Jerold S. Harmatz · 1999 · Journal of Clinical Psychopharmacology
86. Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements
    Nagarjun Rangaraj, Sravanthi Reddy Pailla, Sunitha Sampathi · 2018 · Pulmonary Pharmacology & Therapeutics
87. Variance of Microsomal Protein and Cytochrome P450 2E1 and 3A Forms in Adult Human Liver
    John C. Lipscomb, Linda K. Teuschler, Jeffrey C. Swartout, Cynthia Striley, JOHN E. SNAWDER · 2003 · Toxicology Mechanisms and Methods
88. The role of pharmacogenetically-variable cytochrome P450 enzymes in
    Lisa A. Howard, Edward M. Sellers, Rachel Fynvola Tyndale · 2002 · Pharmacogenomics
89. Involvement of Cytochromes P-450 2E1 and 3A4 in the 5-Hydroxylation of Salicylate in Humans
    Isabelle E. Dupont, Francois Berthou, Pierre Bodénez, L. Bardou, Caroline Guirriec, Nathalie Stephan, Yvonne Dréano, Danièle Lucas · 1999 · Drug Metabolism and Disposition
90. An Evaluation of the Cytochrome P450 Inhibition Potential of Lisdexamfetamine in Human Liver Microsomes
    Krishnan, Suma, Moncrief, Scott · 2007 · Drug Metabolism and Disposition
91. The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant
    Tashinga E. Bapiro, Julia A. Hasler, Marianne Ridderström, Collen Mutowembwa Masimirembwa · 2002 · Biochemical Pharmacology
92. Gut wall metabolism of verapamil in older people: effects of rifampicin‐mediated enzyme induction
    Martin F. Fromm, Karin Dilger, Dagmar Busse · 1998 · British Journal of Clinical Pharmacology
93. Rapid Characterization of the Major Drug-Metabolizing Human Hepatic Cytochrome P-450 Enzymes Expressed in Escherichia coli
    Dermot F. McGinnity, Sarah J. Griffin, Graeme C. Moody, Mike W. Voice, Stephen Hanlon, Thomas Friedberg, Robert J. Riley · 1999 · Drug Metabolism and Disposition
94. Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes
    David F.V Lewis · 2002 · Archives of Biochemistry and Biophysics
95. Metabolism of DHEA by Cytochromes P450 in Rat and Human Liver Microsomal Fractions
    Jennifer L. Fitzpatrick, Sharon L. Ripp, Ned B. Smith, William M. Jr. Pierce, Russell A. Prough · 2001 · Archives of Biochemistry and Biophysics
96. Dig1 protects against cell death provoked by glyphosate-based herbicides in human liver cell lines
    Gasnier, Céline, Benachour, Nora, Clair, Emilie, Travert, Carine, Langlois, Frédéric, Laurant, Claire, Decroix-Laporte, Cécile, Séralini, Gilles-Eric · 2010 · Journal of Occupational Medicine and Toxicology
97. Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European–Brazilian schizophrenics
    Fabiana B. Kohlrausch, Clarissa Severino Gama, Maria Inês Rodrigues Lobato, Paulo Silva Belmonte-de-Abreu, Sidia Maria Callegari-Jacques, Alejandro Gesteira, Francisco Barros, Ángel Carracedo, Mara Helena Hutz · 2008 · Pharmacogenetics and Genomics
98. Significant Increase in Systemic Exposure of Atorvastatin After Biliopancreatic Diversion With Duodenal Switch
    Ine Blankenberg Skottheim, Gunn Signe Jakobsen, Kjartan Stormark, Hege Christensen, Jøran S. Hjelmesaeth, Trond Geir Jenssen, Anders Åsberg, Rune Sandbu · 2010 · Clinical Pharmacology & Therapeutics
99. A gel‐free MS‐based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes
    Michael Zhuo Wang, Judy Qiju Wu, Jennifer B. Dennison et al. · 2008 · PROTEOMICS
100. Dipiperamides A, B, and C: bisalkaloids from the white pepper Piper nigrum inhibiting CYP3A4 activity
     Sachiko Tsukamoto, Bae-Cheon Cha, Tomihisa Ohta · 2002 · Tetrahedron